Aeglea BioTherapeutics

-$0.01 (-0.66%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AGLE and other ETFs, options, and stocks.

About AGLE

Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.

CEO
Anthony G. Quinn
Employees
101
Headquarters
Austin, Texas
Founded
2013

AGLE Key Statistics

Market cap
91.76M
Price-Earnings ratio
—
Dividend yield
—
Average volume
597.77K
High today
$1.53
Low today
$1.45
Open price
$1.53
Volume
147.22K
52 Week high
$8.50
52 Week low
$1.29

AGLE Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure